'Watershed moment’ as London medtech closes £1.75m funding round

Jun 4, 2018 · bdaily.co.uk

Uhhdquic2oitwqrwxnsfzro1asynqs1i9jpksfy3

The medtech company behind a new blood filtration device has secured seven-figure funding.

London-based MediSieve Ltd secured the £1.75m boost from a mix of new and existing investors.

Private capital network 24Haymarket led the round by contributing £632k, with director Marek Gumienny joining the MediSieve board as non-executive director.

MediSieve said the investment will "contribute greatly" to further research and development while providing a strong source of future capital.

The company currently operates from office and lab space at Imperial College London’s Translation & Innovation Hub (I-HUB).

MediSieve is best known for its magnetic blood filtration technology, which targets blood-borne diseases by magnetically filtering specific disease-causing components in the bloodstream.

Read Complete Article

[email protected] returns to London 18-19 July! #unboundLDN announces full agenda including @Marthalanefox, @evarley,… https://t.co/PRSoY8QKV2

1 million EU citizens live in London. Government must ensure any new registration system is quick & simple, with th… https://t.co/ok0WU8bSwC

RT @catalyst_au: On Saturday we completed our 12th international mission, this one to London for @LDNTechWeek with 16 participants from acr…

Box, IBM intro new services for building Box Skills with Watson https://t.co/uOwNHuJPrK

🎀 ⭐ 🎀 @emma_finance are looking for a Software Engineer https://t.co/rnSiUrZR40 #javascript #nodejs